FUCA', GIOVANNI
 Distribuzione geografica
Continente #
EU - Europa 2.377
NA - Nord America 1.706
AS - Asia 1.052
SA - Sud America 83
OC - Oceania 14
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.241
Nazione #
US - Stati Uniti d'America 1.655
DE - Germania 1.298
CN - Cina 650
GB - Regno Unito 365
IT - Italia 216
SG - Singapore 172
SE - Svezia 163
BR - Brasile 70
RU - Federazione Russa 59
IE - Irlanda 55
CA - Canada 48
DK - Danimarca 46
FR - Francia 45
IN - India 44
JP - Giappone 43
HK - Hong Kong 38
ID - Indonesia 26
UA - Ucraina 25
NL - Olanda 20
BE - Belgio 17
TW - Taiwan 16
KR - Corea 15
FI - Finlandia 14
AU - Australia 12
UZ - Uzbekistan 12
ES - Italia 9
PL - Polonia 8
AT - Austria 6
CZ - Repubblica Ceca 6
IR - Iran 6
AR - Argentina 5
GR - Grecia 5
PH - Filippine 5
RO - Romania 5
NO - Norvegia 4
ZA - Sudafrica 4
CH - Svizzera 3
EC - Ecuador 3
IQ - Iraq 3
MX - Messico 3
PE - Perù 3
PK - Pakistan 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
EG - Egitto 2
LB - Libano 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
VN - Vietnam 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
EU - Europa 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
VE - Venezuela 1
Totale 5.241
Città #
Frankfurt am Main 1.210
Southend 305
Chandler 203
Fairfield 156
Ashburn 128
Singapore 122
Milan 93
Ann Arbor 83
Beijing 76
Wilmington 76
Redwood City 67
Dearborn 66
Houston 63
Princeton 62
Cambridge 61
Woodbridge 61
Shanghai 56
Dublin 54
Council Bluffs 51
Seattle 51
Nanjing 35
Guangzhou 34
Phoenix 34
Santa Clara 33
Toronto 31
Shenyang 29
Jinan 24
Central District 23
Des Moines 22
Bengaluru 21
Changsha 21
Jakarta 20
Chengdu 18
Wuhan 18
Zhengzhou 18
Brussels 16
Hebei 15
Los Angeles 15
Helsinki 14
New York 14
Taipei 14
Tianjin 14
Tokyo 14
Nanchang 13
Grafing 12
Falls Church 10
Hangzhou 10
Berlin 9
San Diego 9
London 8
Ningbo 8
Nuremberg 8
Boardman 7
Fuzhou 7
Hong Kong 7
Kansas City 7
Paris 7
Silver Spring 7
Amsterdam 6
Fremont 6
Jiaxing 6
Philadelphia 6
Seoul 6
Xian 6
Andover 5
Baotou 5
Mountain View 5
Nanning 5
Piscataway 5
Rochester 5
San Jose 5
Shenzhen 5
Taizhou 5
Chicago 4
Haikou 4
Hefei 4
Kunming 4
Leipzig 4
Naples 4
Ottawa 4
Quanzhou 4
Redmond 4
Rome 4
Rosharon 4
Voghera 4
Bologna 3
Bühl 3
Cologne 3
Curitiba 3
Duncan 3
Eugene 3
Gunzenhausen 3
Gurgaon 3
Lima 3
Munich 3
Newbury Park 3
Perugia 3
São Paulo 3
Tashkent 3
Tsing Yi Town 3
Totale 3.844
Nome #
Association between Antibiotic-Immunotherapy Exposure Ratio and outcome in metastatic Non Small Cell Lung Cancer 723
Negative hyperselection of patients with RAS and BRAF wild-type metastatic colorectal cancer who received panitumumab-based maintenance therapy 353
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors 223
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs) 211
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study 211
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer 209
Identification and characterization of a novel SCYL3-NTRK1 rearrangement in a colorectal cancer patient 205
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study 203
Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma : A Multicenter, International, Retrospective Study 187
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 179
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 178
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? 174
Role of chemotherapy, VEGFR inhibitors and mTOR Inhibitors in advanced Perivascular Epithelioid Cell Tumours (PEComas) 164
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients : the AMNESIA Case-Control Study 152
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer 139
The landscape of d16HER2 splice variant expression across HER2-positive cancers 139
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer 137
Atypical RAS Mutations in Metastatic Colorectal Cancer 137
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin 133
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram 133
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer 132
Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study 130
Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase 129
Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy 126
RET fusions in a small subset of advanced colorectal cancers at risk of being neglected 123
Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting 123
Exposure to Multiple Lines of Treatment and Survival of Patients With Metastatic Renal Cell Carcinoma : A Real-world Analysis 115
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions 92
Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas : a retrospective MITO group study 90
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies : the PRESSING case-control study 87
Immunotherapy-based combinations : an update 75
Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial 59
Totale 5.471
Categoria #
all - tutte 13.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020245 0 0 0 0 0 0 0 0 0 131 70 44
2020/2021699 73 77 62 47 77 63 48 95 68 40 21 28
2021/2022602 54 30 26 32 32 27 38 28 56 124 47 108
2022/2023647 91 88 55 63 54 103 11 49 86 7 29 11
2023/20241.220 10 33 26 29 79 19 255 170 83 164 173 179
2024/2025960 150 156 129 169 80 60 62 99 55 0 0 0
Totale 5.471